Abstract
Kidney cancer: Sunitinib resistance is futile.
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1038/nrurol.2016.180
Journal: Nature Reviews Urology | Publication Date: Sep 13, 2016 |
Citations: 1 |
Kidney cancer: Sunitinib resistance is futile.
Join us for a 30 min session where you can share your feedback and ask us any queries you have